-
1
-
-
84864005418
-
Brain amyloid and cognition in Lewy body diseases
-
Gomperts SN, Locascio JJ, Marquie M, et al. Brain amyloid and cognition in Lewy body diseases. Mov Disord. 2012;27:965-973.
-
(2012)
Mov Disord
, vol.27
, pp. 965-973
-
-
Gomperts, S.N.1
Locascio, J.J.2
Marquie, M.3
-
2
-
-
54049100454
-
Imaging amyloid deposition in Lewy body diseases
-
Gomperts SN, Rentz DM, Moran E, et al. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008;71:903-910.
-
(2008)
Neurology
, vol.71
, pp. 903-910
-
-
Gomperts, S.N.1
Rentz, D.M.2
Moran, E.3
-
3
-
-
33747762262
-
Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?
-
Jellinger KA, Attems J. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol. 2006;112:253-260.
-
(2006)
Acta Neuropathol
, vol.112
, pp. 253-260
-
-
Jellinger, K.A.1
Attems, J.2
-
4
-
-
33747759536
-
Does striatal pathology distinguish dlb from pdd?
-
Liang T, Noorigian JV, Duda JE. Does striatal pathology distinguish dlb from pdd? Mov Disord. 2006;21:S69-S70.
-
(2006)
Mov Disord
, vol.21
-
-
Liang, T.1
Noorigian, J.V.2
Duda, J.E.3
-
5
-
-
78650626088
-
Striatal Abeta peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes
-
Kalaitzakis ME, Walls AJ, Pearce RK, Gentleman SM. Striatal Abeta peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes. Neurobiol Dis. 2011;41:377-384.
-
(2011)
Neurobiol Dis
, vol.41
, pp. 377-384
-
-
Kalaitzakis, M.E.1
Walls, A.J.2
Pearce, R.K.3
Gentleman, S.M.4
-
6
-
-
84858336551
-
Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies
-
20012
-
Kantarci K, Yang C, Schneider JA, et al. Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies. Neurobiol Aging. 20012;33:878-885.
-
Neurobiol Aging
, vol.33
, pp. 878-885
-
-
Kantarci, K.1
Yang, C.2
Schneider, J.A.3
-
7
-
-
74049124939
-
In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
-
Burack MA, Hartlein J, Flores HP, Taylor-Reinwald L, Perlmutter JS, Cairns NJ. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology. 2010;74:77-84.
-
(2010)
Neurology
, vol.74
, pp. 77-84
-
-
Burack, M.A.1
Hartlein, J.2
Flores, H.P.3
Taylor-Reinwald, L.4
Perlmutter, J.S.5
Cairns, N.J.6
-
8
-
-
43849083580
-
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
-
Ikonomovic MD, Klunk WE, Abrahamson EE, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain. 2008;131:1630-1645.
-
(2008)
Brain
, vol.131
, pp. 1630-1645
-
-
Ikonomovic, M.D.1
Klunk, W.E.2
Abrahamson, E.E.3
-
9
-
-
84873647470
-
Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
-
Gomperts SN, Locascio JJ, Rentz D, et al. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology. 2013;80:85-91.
-
(2013)
Neurology
, vol.80
, pp. 85-91
-
-
Gomperts, S.N.1
Locascio, J.J.2
Rentz, D.3
|